20n Bio


20n Bio is a VC-backed startup dedicated to discovering cyclic peptides for therapeutic use. Based in the Greater Philadelphia region, their mission is to address unmet medical needs by leveraging high-throughput screening and chemical optimization to develop peptide drugs across various therapeutic areas. They have developed a proprietary platform capable of screening trillions of peptides to identify potent candidates and have built partnerships with pharmaceutical and biotech companies.

Industries

biotechnology

Nr. of Employees

small (1-50)

20n Bio

Malvern, Pennsylvania, United States, North America


Products

Proprietary peptide discovery platform

An integrated discovery platform capable of screening ultra-large peptide libraries and supporting downstream chemical optimization to identify high-affinity peptide candidates.


Services

Peptide discovery partnerships and licensing

Licensing of early discovery hits and collaborative discovery projects with pharmaceutical and biotechnology companies.

Customized peptide discovery services

Tailored discovery services combining ultra-large library screening and chemical optimization to generate candidate peptides for specified targets or modalities.

Expertise Areas

  • Peptide discovery
  • High-throughput screening and selection
  • Computational protein/peptide design
  • Lead optimization and medicinal chemistry for peptides
  • Show More (2)

Key Technologies

  • Ultra-large peptide libraries
  • Cyclic peptide discovery
  • High-throughput screening
  • Computational design algorithms for peptides/proteins
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.